Copy Number Abnormalities May Inform Survival, Drug Resistance

Copy Number Abnormalities May Inform Survival, Drug Resistance

August 13, 2018 For cancers associated with numerous copy number changes, it is difficult to assign disease classifiers and identify useful targets for drug development. In a study published in Nature Genetics, researchers showed that categorizing copy number abnormalities into distinct sets from […]

FDA expands blood pressure drug recall due to cancer concerns

FDA expands blood pressure drug recall due to cancer concerns

The U.S. Food and Drug Administration is expanding a recall of drug products containing the ingredient valsartan, which is used to treat high blood pressure and heart failure. The FDA first issued a voluntary recall in July after results from laboratory tests revealed that some drugs may have been tainted with the substance N-nitrosodimethylamine or […]

New ovarian cancer medicine approved for use by NHS Scotland

New ovarian cancer medicine approved for use by NHS Scotland

The approval of a new drug to treat ovarian cancer in Scotland has been welcomed by campaigners. The Scottish Medicines Consortium (SMC) has accepted niraparib (Zejula) for use by NHS Scotland for advanced ovarian cancer. It is said to be the first maintenance treatment for patients with ovarian cancer who do not have the BRCA mutation […]

Blood pressure drug recalled for cancer concerns

Blood pressure drug recalled for cancer concerns

A popular blood pressure and heart medication known as Valsartan Tablets has been recalled due to possible carcinogen contamination.  The Food and Drug Administration announced last week that all Valsartan Tablets, which come in sizes ranging from 40 mg to 320 mg, were being recalled because trace amounts of cancer-causing agents were detected. Nitrosodimethylamine, or NDMA, a substance […]

High blood pressure drug recall expanded by FDA over cancer concerns

High blood pressure drug recall expanded by FDA over cancer concerns

The Food and Drug Administration has expanded the recall of a common blood pressure medication over the concern that the drugs may contain a cancer-causing substance.  Valsartan, according to the FDA, is used as a component in drugs used to treat high blood pressure and congestive heart failure. The first recall was made on July […]

Dr Reddy's eyeing European market for cancer drug

Dr Reddy's eyeing European market for cancer drug

Natco Pharma today said its co-development and marketing partner Dr Reddys Laboratories Ltd has filed an application with the European Medicines Agency for marketing a cancer drug in Europe. In a press release here, Natco said the duxorubicinhydrochloride liposome injection, a therapeutic equivalent to the generic version of Jessens Doxil, is for intravenous use for […]

Fierce competition in China's nascent immuno-therapy cancer drugs market could compromise safety, say analysts

Fierce competition in China's nascent immuno-therapy cancer drugs market could compromise safety, say analysts

China’s huge cancer-treatment market is a potential gold mine for drug developers. But fierce competition to get a new group of medicines approved could see prices fall rapidly and the market fragment into tiers of products with varying efficacy and safety, analysts say. Anti-PD-1 drugs and T-cell engineering, types of immuno-therapy treatments that use the […]